Ethics and etiquette in an emergency vaccine trial. The orchestration of compliance
Participant non-compliance and withdrawal from randomized clinical trials has increased focus on analysing the results from the “per-protocol” population that complies with a trial’s protocols. There is no clear understanding of what shapes protocol compliance in practice. In this paper, I theorize...
Main Author: | Arsenii Alenichev |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Global Bioethics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/11287462.2020.1726591 |
Similar Items
-
Precarity, clinical labour and graduation from Ebola clinical research in West Africa
by: Arsenii Alenichev, et al.
Published: (2019-01-01) -
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
by: Moses Badio, et al.
Published: (2021-01-01) -
Ebola Vaccine: How Far are we?
by: Rajani Sharma, et al.
Published: (2017-05-01) -
Are trial participants adequately safeguarded by the ethics committees – the Indian scenario?
by: Karan eThakkar, et al.
Published: (2014-06-01) -
Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease
by: Shani Cohen, et al.
Published: (2018-12-01)